Skip to main content
TipRanks
Go Ultimate75% OFF

RAVI YANG SARIN Insider Profile

4 Followers

RAVI YANG SARIN, Director at Starling Oncology Institute, holds 4.19M shares in Starling Oncology Institute (Ticker: STLN).

RAVI YANG SARIN's Trading History

STLN
Starling Oncology Institute
Mar 21, 2023DirectorUninformative Buy―$14.65M
STLN
Insider Shares: 4.19M (5.61%)

RAVI YANG SARIN has not reported any informative transactions for STLN, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 21, 2023Uninformative Buy$0.0029,528$0.00―
Nov 21, 2022Uninformative Buy$0.0022,708$0.00―
Mar 23, 2022Uninformative Buy$0.0023,191$0.00―
Nov 16, 2021Uninformative Buy$0.004,109,771$0.00―

You May Also Like

RAVI YANG SARIN insider profile FAQ

What stocks does RAVI YANG SARIN hold?
RAVI YANG SARIN holds: STLN stocks.
What is RAVI YANG SARIN's role in Starling Oncology Institute?
RAVI YANG SARIN's role in Starling Oncology Institute is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.